Rickets, Hypophosphatemic: Clinical Trials

10 trials for Rickets, Hypophosphatemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 recruiting, 1 terminated, 1 unknown. 10 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 7, Recruiting 1, Terminated 1, Unknown 1
Phase 25Completed 4, Recruiting 1

Follow Rickets, Hypophosphatemic: new trials by email Literature Review of Rickets, Hypophosphatemic trials Research Report on Rickets, Hypophosphatemic

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
KK8123 - X-linked Hypophosphatemia
Phase 1 / Phase 2RecruitingKyowa Kirin Co., Ltd.392024-10-092026-11-06
Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
Burosumab - X-linked Hypophosphatemia (XLH)
Phase 1 / Phase 2CompletedKyowa Kirin Pharmaceutical Development Ltd162020-02-262024-11-07
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
KRN23 - X-linked Hypophosphatemic Rickets/Osteomalacia
Phase 1CompletedKyowa Kirin Co., Ltd.152014-07-012017-03-03
Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Osteomalacia - Osteomalacia
Phase 1TerminatedNational Institute of Dental and Craniofacial Research (NIDCR)12012-11-162018-07-05
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.232012-02-012024-06-18
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.292011-04-012024-06-18
A Study of KRN23 in X-linked Hypophosphatemia
Placebo, KRN23 - X-linked Hypophosphatemia
Phase 1CompletedKyowa Kirin Co., Ltd.422008-12-012024-06-17
Growth Hormone Treatment in Children With Hypophosphatemic Rickets
norditropine simplex - X Linked Hypophosphatemic Rickets
Phase 1 / Phase 2CompletedBicetre Hospital192006-01-012016-03-28
Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Cinacalcet - Hypophosphatemic Rickets, X-Linked Dominant
Phase 1CompletedChildren's Mercy Hospital Kansas City82005-06-012021-01-19
Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
somatropin - Hypophosphatemic Rickets, Growth Disorders
Phase 1UnknownUniversity of Rostock2004-08-012007-05-14

Narrower conditions

Familial Hypophosphatemic Rickets (9)  ·  Osteomalacia (2)  ·  Bone Diseases (1)  ·  Growth Disorders (1)  ·  Hypophosphatemia (1)  ·  Kidney Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Oncogenic osteomalacia (1)  ·  Rare Diseases (1)

Broader conditions

Avitaminosis (10)  ·  Bone Diseases, Metabolic (10)  ·  Calcium Metabolism Disorders (10)  ·  Deficiency Diseases (10)  ·  Malnutrition (10)  ·  Nutrition Disorders (10)  ·  Nutritional and Metabolic Diseases (10)  ·  Phosphorus Metabolism Disorders (10)  ·  Rickets (10)  ·  Vitamin D Deficiency (10)  ·  Bone Diseases (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Genetic Diseases, Inborn (9)

Interventions

burosumab (5)  ·  Cinacalcet (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)

Sponsors

Kyowa Kirin Co., Ltd. (5)  ·  Bicetre Hospital (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Kyowa Kirin Pharmaceutical Development Ltd (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  University of Rostock (1)

Countries

United States (6)  ·  Canada (3)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  Austria (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Amy Zhang, PhD (2)  ·  Dieter Haffner, MD (1)  ·  Dirk Schnabel, MD (1)  ·  Hagen Staude (1)  ·  Rachel I Gafni, M.D. (1)  ·  Rachel Levy-Olomucki, MD (1)  ·  Thomas O. Carpenter, M.D. (1)

Results publications

PMID 25919461, PMID 24569459, PMID 26073451, PMID 28822957, PMID 39151033, PMID 42044650